Identification of a Hypoxia-Related Signature for Predicting Prognosis and the Immune Microenvironment in Bladder Cancer
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Identification of a Hypoxia-Related Signature for Predicting Prognosis and the Immune Microenvironment in Bladder Cancer
Authors
Keywords
-
Journal
Frontiers in Molecular Biosciences
Volume 8, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-05-07
DOI
10.3389/fmolb.2021.613359
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2020
- (2020) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Identifying the mRNAs associated with Bladder cancer recurrence
- (2020) Huifeng Cao et al. Cancer Biomarkers
- European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines
- (2020) J. Alfred Witjes et al. EUROPEAN UROLOGY
- LncRNA HOTAIR promotes the growth and metastasis of gastric cancer by sponging miR-1277-5p and upregulating COL5A1
- (2020) Zhijian Wei et al. Gastric Cancer
- Assessment of Luminal and Basal Phenotypes in Bladder Cancer
- (2020) Charles C. Guo et al. Scientific Reports
- Mechanisms of BCG in the treatment of bladder cancer-current understanding and the prospect
- (2020) Jiansong Han et al. BIOMEDICINE & PHARMACOTHERAPY
- PD-L1 protein expression in non-small-cell lung cancer and its relationship with the hypoxia-related signaling pathways: A study based on immunohistochemistry and RNA sequencing data
- (2019) Young Wha Koh et al. LUNG CANCER
- The new identified biomarkers determine sensitivity to immune check-point blockade therapies in melanoma
- (2019) Hao Chen et al. OncoImmunology
- DNA damage repair gene mutations and their association with tumor immune regulatory gene expression in muscle invasive bladder cancer subtypes
- (2019) Thiago Vidotto et al. Journal for ImmunoTherapy of Cancer
- European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ) - 2019 Update
- (2019) Marko Babjuk et al. EUROPEAN UROLOGY
- Investigation of candidate molecular biomarkers for expression profile analysis of the Gene expression omnibus (GEO) in acute lymphocytic leukemia (ALL)
- (2019) Guojun Zhang et al. BIOMEDICINE & PHARMACOTHERAPY
- Mechanisms of immune evasion in bladder cancer
- (2019) Paul L. Crispen et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Phase 2 Trial of Gemcitabine, Cisplatin, plus Ipilimumab in Patients with Metastatic Urothelial Cancer and Impact of DNA Damage Response Gene Mutations on Outcomes
- (2018) Matthew D. Galsky et al. EUROPEAN UROLOGY
- Atezolizumab versus chemotherapy in patients with platinum-treated locally advanced or metastatic urothelial carcinoma (IMvigor211): a multicentre, open-label, phase 3 randomised controlled trial
- (2018) Thomas Powles et al. LANCET
- Mechanisms of BCG immunotherapy and its outlook for bladder cancer
- (2018) Caroline Pettenati et al. Nature Reviews Urology
- Emerging Role of Immunotherapy in Advanced Urothelial Carcinoma
- (2018) Vadim S. Koshkin et al. Current Oncology Reports
- Immuno-Oncology: Emerging Targets and Combination Therapies
- (2018) Henry T. Marshall et al. Frontiers in Oncology
- Targeted regulation by ROCK2 on bladder carcinoma via Wnt signaling under hypoxia
- (2018) Junfeng Luo et al. Cancer Biomarkers
- Prognostic Impact of a 12-gene Progression Score in Non–muscle-invasive Bladder Cancer: A Prospective Multicentre Validation Study
- (2017) Lars Dyrskjøt et al. EUROPEAN UROLOGY
- Annexin A2 and cancer: A systematic review
- (2017) Maria Christensen et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Unlocking bladder cancer
- (2017) Chris Berdik NATURE
- A review of the PD-1/PD-L1 checkpoint in bladder cancer: From mediator of immune escape to target for treatment 1 1MPS is an investor in and consultant for Urogen. SAP is consultant and advisor for Vaccinex. The remaining authors have nothing to disclose.
- (2017) Tian C. Zhou et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Pan-cancer Immunogenomic Analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint Blockade
- (2017) Pornpimol Charoentong et al. Cell Reports
- Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of bladder carcinoma
- (2017) Ashish M. Kamat et al. Journal for ImmunoTherapy of Cancer
- The Leloir Pathway of Galactose Metabolism – A Novel Therapeutic Target for Hepatocellular Carcinoma
- (2016) MANSHU TANG et al. ANTICANCER RESEARCH
- DeCoN: Genome-wide Analysis of In Vivo Transcriptional Dynamics during Pyramidal Neuron Fate Selection in Neocortex
- (2015) Bradley J. Molyneaux et al. NEURON
- limma powers differential expression analyses for RNA-sequencing and microarray studies
- (2015) Matthew E. Ritchie et al. NUCLEIC ACIDS RESEARCH
- Identification of Distinct Basal and Luminal Subtypes of Muscle-Invasive Bladder Cancer with Different Sensitivities to Frontline Chemotherapy
- (2014) Woonyoung Choi et al. CANCER CELL
- Hypoxia downregulates the expression of activating receptors involved in NK-cell-mediated target cell killing without affecting ADCC
- (2013) Mirna Balsamo et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- DNA Based Therapy with Diphtheria Toxin-A BC-819: A Phase 2b Marker Lesion Trial in Patients with Intermediate Risk Nonmuscle Invasive Bladder Cancer
- (2013) Ofer N. Gofrit et al. JOURNAL OF UROLOGY
- Inferring tumour purity and stromal and immune cell admixture from expression data
- (2013) Kosuke Yoshihara et al. Nature Communications
- A Molecular Taxonomy for Urothelial Carcinoma
- (2012) G. Sjodahl et al. CLINICAL CANCER RESEARCH
- Integrated Genomic and Gene Expression Profiling Identifies Two Major Genomic Circuits in Urothelial Carcinoma
- (2012) David Lindgren et al. PLoS One
- Expression Signature of E2F1 and Its Associated Genes Predict Superficial to Invasive Progression of Bladder Tumors
- (2010) Ju-Seog Lee et al. JOURNAL OF CLINICAL ONCOLOGY
- Predictive value of progression-related gene classifier in primary non-muscle invasive bladder cancer
- (2010) Wun-Jae Kim et al. Molecular Cancer
- Statistical methods of background correction for Illumina BeadArray data
- (2009) Yang Xie et al. BIOINFORMATICS
- How To Build and Interpret a Nomogram for Cancer Prognosis
- (2008) Alexia Iasonos et al. JOURNAL OF CLINICAL ONCOLOGY
- Human dendritic cells differentiated in hypoxia down-modulate antigen uptake and change their chemokine expression profile
- (2008) Angela Rita Elia et al. JOURNAL OF LEUKOCYTE BIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started